Products - Hepatitis | Topic | NICE

Showing 37 products

Date | Sort by Title

Hepatitis B (chronic)
Product type:
Pathway
Last updated:
16 January 2020
Hepatitis B and C testing
Product type:
Pathway
Last updated:
10 August 2017
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C (MTG27)
Product type:
Guidance
Programme:
Medical technologies guidance
Last updated:
17 January 2020
Published date:
23 September 2015
Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C (TA507)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
21 February 2018
Glecaprevir–pibrentasvir for treating chronic hepatitis C (TA499)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
24 January 2018
Hepatitis B (chronic): diagnosis and management (CG165)
Product type:
Guidance
Programme:
Clinical guideline
Last updated:
20 October 2017
Published date:
26 June 2013
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal) (TA435)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
22 March 2017
Sofosbuvir–velpatasvir for treating chronic hepatitis C (TA430)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
25 January 2017
Elbasvir–grazoprevir for treating chronic hepatitis C (TA413)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
26 October 2016
Ledipasvir–sofosbuvir for treating chronic hepatitis C (TA363)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
25 November 2015
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C (TA365)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
25 November 2015
Sofosbuvir for treating chronic hepatitis C (TA330)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
25 February 2015
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people (TA300)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
27 November 2013
Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C (TA75)
Product type:
Guidance
Programme:
Technology appraisal guidance
Last updated:
1 November 2013
Published date:
28 January 2004
Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C (TA106)
Product type:
Guidance
Programme:
Technology appraisal guidance
Last updated:
1 November 2013
Published date:
23 August 2006
Hepatitis B and C testing: people at risk of infection (PH43)
Product type:
Guidance
Programme:
Public health guideline
Last updated:
1 March 2013
Published date:
12 December 2012
Stent insertion for bleeding oesophageal varices (IPG392)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published date:
27 April 2011
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C (TA200)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
22 September 2010
Tenofovir disoproxil for the treatment of chronic hepatitis B (TA173)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
22 July 2009
Entecavir for the treatment of chronic hepatitis B (TA153)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
27 August 2008
Telbivudine for the treatment of chronic hepatitis B (TA154)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
27 August 2008
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B (TA96)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
22 February 2006
The OraQuick HCV point‑of‑care test for rapid detection of hepatitis C virus antibodies (MIB24)
Product type:
Advice
Programme:
Medtech innovation briefing
Published date:
2 March 2015
Hepatitis B (QS65)
Product type:
Quality standard
Published date:
28 July 2014
Hepatitis C (genotype 1, chronic) - faldaprevir [ID670]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Bulevirtide for treating chronic hepatitis D [ID3732]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Collaborating with community pharmacists to deliver sexual health services
Product type:
Shared learning
Published date:
31 January 2019
Bolton Integrated Drug and Alcohol Service (BiDAS) Steroid Clinic
Product type:
Shared learning
Published date:
22 June 2017
Improving the uptake of Hepatitis B screening and vaccination in at-risk groups attending the sexual health service
Product type:
Shared learning
Published date:
15 March 2016
Use of transient elastography to assess liver disease in people with chronic hepatitis B
Product type:
Shared learning
Published date:
29 May 2013
Using the hepatitis B surface antigen (HBsAg) quantitative assay test to evaluate patient response to treatment for chronic hepatitis B virus infection
Product type:
Shared learning
Published date:
16 May 2013
Hepatitis information and testing in Sheffield: Outreach pilot for high prevalence communities
Product type:
Shared learning
Published date:
8 April 2013
The Spectrum hepatitis C support service.
Product type:
Shared learning
Published date:
8 April 2013
Yorkshire and the Humber Hepatitis Project
Product type:
Shared learning
Published date:
8 April 2013
Mind the Gap
Product type:
Shared learning
Published date:
20 November 2012
Hepatitis C GP Awareness Project
Product type:
Shared learning
Published date:
1 June 2012
Developing a Greater Manchester Hepatitis C Service Specification
Product type:
Shared learning
Published date:
28 September 2011